Allozymes
Type
startup
Founded
2020
Funding captured
$20.8m
Deals captured
3
About Allozymes
Allozymes is a Singapore-based biotechnology company that is redefining enzyme engineering through its proprietary ultra-high-throughput microfluidic and AI-driven screening platform. The firm aims to replace traditional, resource-intensive manufacturing methods with cleaner, greener, and more scalable biosolutions.
Allozymes funding captured (3)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Equity | Series A | May 14, 2024 | $15.0m |  SOSV +5 |
| **************** | **************** | **************** | $5.0m | **************** |
| **************** | **************** | **************** | $750.0k | **************** |